2012
DOI: 10.1128/jvi.00512-12
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated Heterologous Adenovirus Prime-Boost SIV Vaccine in Neonatal Rhesus Monkeys

Abstract: A pediatric human immunodeficiency virus type 1 (HIV-1) vaccine would be desirable to protect infants against HIV-1 transmission from breast-feeding. Such a vaccine would need to induce protective immunity at mucosal surfaces in neonates as soon as possible after birth. Recombinant adenovirus (rAd) vectors have been shown to elicit potent systemic and mucosal virus-specific immune responses in adult nonhuman primates and humans, but these vectors have not previously been comprehensively studied in infants. In … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
5
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 44 publications
(63 reference statements)
1
5
0
Order By: Relevance
“…Thus, our results demonstrate a profound Th1 bias of the immune response in both adult and neonatal mice after Ad26.RSV.preF immunization. These data are in line with previously published data on newborn rhesus monkeys showing that an Ad26 vectored vaccine induces CD4+ and CD8+ T cells producing IFN-γ when given on the day of birth 45 . Altogether this indicates that the Adenoviral vector platform is able to overcome the Th2 bias of the neonatal immune system, and instead induces Th1-biased responses.…”
Section: Discussionsupporting
confidence: 92%
“…Thus, our results demonstrate a profound Th1 bias of the immune response in both adult and neonatal mice after Ad26.RSV.preF immunization. These data are in line with previously published data on newborn rhesus monkeys showing that an Ad26 vectored vaccine induces CD4+ and CD8+ T cells producing IFN-γ when given on the day of birth 45 . Altogether this indicates that the Adenoviral vector platform is able to overcome the Th2 bias of the neonatal immune system, and instead induces Th1-biased responses.…”
Section: Discussionsupporting
confidence: 92%
“…Macaque CD45RO+ cells have high levels of the markers CD95 and CCR5, which are enriched on memory cells, the latter particularly in gut-associated tissues (Figures 4 and 8). In macaques, memory cells have been subdivided into subsets based on the expression of CD28, CD95, and CCR7, where CD95+ CCR7 - CD28+ defines transitional memory T cells (T TM ), CD95+ CCR7- CD28- defines effector memory (T EM ), and CD95+ CCR7+ CD28+ central memory (T CM ) [34]. In the PBMC and in the gut, the majority of CD45RO+ cells express both CD28 and CD95, and thus are either T CM or T TM .…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that this baby was inoculated parenterally with maternal cells instead of mucosally with virus, resulting in rapid viremia without a previremic eclipse phase of viral replication in mucosal and lymphoid tissues. The positive outcome in this baby might therefore have reflected the route of transmission, the lack of an eclipse phase in tissues, the very rapid initiation of ART, and/or the paucity of memory CD4+ T lymphocytes in the neonatal immune system 29 .…”
mentioning
confidence: 99%